Back to Search
Start Over
Acquired resistance or tolerance? - in search of mechanisms underlying changes in the resistance profile of Candida albicans and Candida parapsilosis as a result of exposure to methotrexate.
- Source :
-
Journal de mycologie medicale [J Mycol Med] 2024 Jun; Vol. 34 (2), pp. 101476. Date of Electronic Publication: 2024 Mar 15. - Publication Year :
- 2024
-
Abstract
- The increasing prevalence of fungal strains showing acquired resistance and multidrug resistance is an increasing therapeutic problem, especially in patients with a severely weakened immune system and undergoing chemotherapy. What is also extremely disturbing is the similarity of the resistance mechanisms of fungal cells and other eukaryotic cells, including human cells, which may contribute to the development of cross-resistance in fungi in response to substances used in e.g. anticancer treatment. An example of such a drug is methotrexate, which is pumped out of eukaryotic cells by ABC transmembrane transporters - in fungi, used to remove azoles from fungal cells. For this reason, the aim of the study was to analyze the expression levels of genes: ERG11, MDR1 and CDR1, potentially responsible for the occurrence of cross-resistance in Candida albicans and Candida parapsilosis as a result of fungal exposure to methotrexate (MTX). In vitro exposure of C. albicans and C. parapsilosis strains to methotrexate showed a high increase in resistance to fluconazole and a partial increase in resistance to voriconazole. Analysis of the expression of resistance genes showed varied responses of the tested strains depending on the species. In the case of C. albicans, an increase in the expression of the MDR1 gene was observed, and a decrease in ERG11 and CDR1. However, for C. parapsilosis there was an increase in the expression of the CDR1 gene and a decrease in ERG11 and MDR1. We noted the relationship between the level of resistance to voriconazole and the level of ERG11 gene expression in C. albicans. This indicates that this type of relationship is different for each species. Our research confirms that the mechanisms by which fungi acquire resistance and develop cross-resistance are highly complex and most likely involve several pathways simultaneously. The emergence of multidrug resistance may be related to the possibility of developing tolerance to antimycotics by fungi.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.)
- Subjects :
- Humans
Voriconazole pharmacology
Gene Expression Regulation, Fungal drug effects
Candidiasis microbiology
Candidiasis drug therapy
Membrane Transport Proteins genetics
ATP Binding Cassette Transporter, Subfamily B, Member 1 genetics
Drug Resistance, Multiple, Fungal genetics
Methotrexate pharmacology
Candida albicans drug effects
Candida albicans genetics
Antifungal Agents pharmacology
Candida parapsilosis drug effects
Candida parapsilosis genetics
Fungal Proteins genetics
Fluconazole pharmacology
Drug Resistance, Fungal genetics
Microbial Sensitivity Tests
Subjects
Details
- Language :
- English
- ISSN :
- 1773-0449
- Volume :
- 34
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Journal de mycologie medicale
- Publication Type :
- Academic Journal
- Accession number :
- 38507825
- Full Text :
- https://doi.org/10.1016/j.mycmed.2024.101476